Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johnson & Johnson has won Food and Drug Administration approval for a catheter that delivers radiofrequency and pulsed field energy to treat atrial fibrillation. The approval, which J&J disclosed Wednesday, covers the Dual Energy Thermocool…
WASHINGTON — The Trump administration’s pick to oversee preparedness and response to public health emergencies and disasters has questioned the use of the hepatitis B vaccine in infants and raised the disproven link between vaccines and autism in past comments reviewed by STAT. Those comments by Sean Kaufman, nominated to be Assistant Secretary for Preparedness…
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Healthcare workers at both Mass General Brigham in Boston and Mount Nittany Medical Center in Pennsylvania have announced strikes this week as employment contract negotiations grow increasingly contentious in the industry. About 4,500 workers at Mass General’s…
Ask any data security leader at a health plan what keeps them up at night and the answer usually isn’t a single threat. It’s the environment: member data that’s among the most sensitive anywhere, regulatory obligations that expand every legislative session, and a data ecosystem that grows more complex every time a new contributing plan…
Dive Brief: Illumina has named two executives to lead its commercial and legal affairs teams. Mike Sullivan will join Illumina as chief commercial officer on July 20 and Julie Coletti will join as chief legal officer starting Aug. 3, according to a Thursday announcement. The appointments come as Illumina’s sales have stabilized following a period…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. ARPA-H has unveiled a $160 million effort to speed bespoke gene-editing therapies for rare diseases into the clinic. Meanwhile, Roche has abandoned two Huntington’s gene-silencing drugs after disappointing data, and drugmakers have stepped in to…
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Resmed has agreed to sell its MatrixCare software business for $490 million to private equity firm Frazier Healthcare Partners. The deal is meant to sharpen Resmed’s focus on sleep and breathing health devices and connected,…
Kevin Deutsch, Chief Growth Officer at Softheon The price shock from soaring 2026 ACA (Affordable Care Act) premiums is reshaping how Americans think about and shop for their health coverage. This environment creates an opportunity for provider-sponsored health plans (PSHPs) to step in and deliver more patient-focused care and coverage to their communities. The average…
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Stereotaxis said Thursday it finalized the acquisition of French surgical robotics company Robocath. Announced in April, the deal is valued at up to $45 million and brings together two robot developers focused on endovascular interventions,…
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Why does getting family health insurance…